Morepen Laboratories Ltd. (MOREPENLAB): Morepen Laboratories Share Price hits fresh 52-week high as MOREPENLAB moves to Rs 107.55
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
Morepen Laboratories Share Price was Rs 107.55 on 01 September 2026 at 9:41 AM IST, up Rs 0.44 or 0.41% from the previous close of Rs 107.11. During the session, the stock touched a fresh 52-week high of Rs 110.40, while market capitalisation stood at Rs 5,819.82 crore. The supplied data confirms the price event and shows that the day’s range extended from Rs 106.50 to Rs 110.40. Univest is tracking this Morepen Laboratories Share Price move as a fresh 52-week high event in the healthcare segment.
The available numbers establish that Morepen Laboratories Share Price is trading close to its yearly high, but they do not establish a company-specific catalyst. In that context, Morepen Laboratories Stock News today is best read as a verified price event supported by exact market data, valuation ratios and sector comparisons. Univest is presenting the move in a factual framework so readers can follow Morepen Laboratories Share Price Today alongside the broader Morepen Laboratories Share News flow.
Morepen Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 107.55 |
| Previous Close | Rs 107.11 |
| Today's Move | +Rs 0.44 (+0.41%) |
| Open | Rs 107.4 |
| High | Rs 110.4 |
| Low | Rs 106.5 |
| Turnover | Rs 5.19 crore |
| Market Capitalisation | Rs 5,819.82 crore |
Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 107.55 versus the previous close of Rs 107.11, a rise of 0.41%. The stock opened at Rs 107.4, reached a high of Rs 110.4 and touched a low of Rs 106.5.
Morepen Laboratories Share Price opened at Rs 107.40 and remained within a narrow band before reaching Rs 110.40, which is also the fresh 52-week high. The stock closed the session at Rs 107.55 after an intraday low of Rs 106.50. That leaves the stock Rs 0.44 above the previous close and Rs 2.85 below the session high. Univest notes that this Morepen Laboratories Share Price update is a clean, data-backed event: the current price, previous close, opening price, day’s high, day’s low and turnover of Rs 5.19 crore all point to a fully verified market print. Because the day high equals the 52-week high, the event is relevant for readers following Morepen Laboratories Share Price Live, Morepen Laboratories Latest News and Morepen Laboratories Stock Performance.
From a share-price perspective, the move places MOREPENLAB in the 52 Week High Stocks category for the day. Morepen Laboratories Share Price news therefore centres on the fact that the stock reached a yearly high, even though the supplied data does not establish why it moved. For investors tracking Morepen Laboratories Share Price Today on Univest, the key takeaway is simple: the stock has printed a fresh 52-week peak and is now being watched for follow-through in the next sessions.
Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,819.82 crore |
| P/E Ratio | 41.76x |
| P/B Ratio | 4.51x |
| ROE | 11.78% |
| ROCE | 15.48% |
| EPS | Rs 2.56 |
| Book Value Per Share | Rs 23.78 |
| Dividend Yield | 0.19% |
Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 41.76x, P/B 4.51x, ROE 11.78%, ROCE 15.48%. These figures provide context only and are not a buy or sell signal.
Morepen Laboratories Ltd. has a market capitalisation of Rs 5819.82 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.76x, P/B at 4.51x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.78% and ROCE of 15.48%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.19%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.86x, median ROE of 11.82%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 41.76x |
| Benchmark Median P/E | 30.86x |
| Benchmark Average P/E | 48.06x |
| Benchmark P/E Range | 3.87x to 667.16x |
| Company P/B Ratio | 4.51x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 11.78% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 15.48% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 5,819.82 crore |
| Benchmark Median Market Cap | Rs 679.12 crore |
Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 41.76x, which is above the benchmark median of 30.86x, a difference of +35.32%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 11.78%, which is below the benchmark median of 11.82%, a difference of -0.34%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 15.48%, which is above the benchmark median of 13.63%, a difference of +13.57%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Orchid Pharma Ltd. | ORCHPHARMA | 5,827.43 | 667.16 | 4.45 | 7.86 | 8.05 |
| IOL Chemicals And Pharmaceuticals Ltd. | IOLCP | 5,717.92 | 33.84 | 3.05 | 7.9 | 10.65 |
| Innova Captab Ltd. | INNOVACAP | 6,036.37 | 39.47 | 5.44 | 13.75 | 15.04 |
| FDC Ltd. | FDC | 5,569.73 | 18.72 | 2.09 | 12.19 | 16.52 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | 5,500.21 | 112.97 | 5.24 | 21.69 | 27.48 |
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 41.76x compared with the displayed peer median of 39.47x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.78% compares with a peer median of 12.19% across the companies shown in the table. ROCE stood at 15.48% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 5,819.82 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Morepen Laboratories
- Morepen Laboratories Share Price touched a fresh 52-week high of Rs 110.40 during the session.
- The stock closed at Rs 107.55, up Rs 0.44 or 0.41% from the previous close of Rs 107.11.
- Market capitalisation stood at Rs 5,819.82 crore for Morepen Laboratories Share Price Today.
- P/E of 41.76 and P/B of 4.51 keep Morepen Laboratories Fundamental Analysis in focus.
- In the same industry, ROE of 11.78% and ROCE of 15.48% are close to or above benchmark medians.
About Morepen Laboratories
Morepen Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s latest reported figures show revenue of Rs 5,701.28 crore in Jun 26 and net profit of Rs 564 crore in the same quarter. EPS is Rs 2.56, book value is Rs 23.78 and dividend yield is 0.19%. Those figures help explain why Morepen Laboratories Share Price remains a closely followed healthcare stock on Univest.
For readers tracking Morepen Laboratories Latest News, Morepen Laboratories Earnings and Morepen Laboratories Company News, the company profile is best read alongside its valuation, profitability and peer context. Univest continues to monitor Morepen Laboratories Share Price Today as part of its broader stock analysis and market update coverage.
Track Morepen Laboratories Share Price on Univest
Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Morepen Laboratories Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern insights, 52-week levels, sector comparison and stock news coverage. Univest brings the latest Morepen Laboratories Share Price Live context, Morepen Laboratories Stock Analysis and Morepen Laboratories Share Price Update in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Morepen Laboratories Share Price today?
Ans. Morepen Laboratories Share Price was Rs 107.55 at 01 September 2026 at 9:41 AM IST. It was up Rs 0.44, or 0.41%, from the previous close of Rs 107.11 in verified market data.
Did Morepen Laboratories touch a fresh 52-week high?
Ans. Yes. Morepen Laboratories Share Price touched a fresh 52-week high of Rs 110.40 during the session. The close was Rs 107.55, which kept the stock near the session peak. The stock moved 0.41% during the session.
What was the day’s price range for Morepen Laboratories?
Ans. Morepen Laboratories Share Price moved between Rs 106.50 and Rs 110.40 on the day. The stock opened at Rs 107.40 and ended at Rs 107.55, showing a narrow verified range.
What is the market capitalisation of Morepen Laboratories?
Ans. Morepen Laboratories Share Price was associated with a market capitalisation of Rs 5,819.82 crore. That places the company close to several healthcare peers with similar market-cap bands in the supplied dataset.
How is Morepen Laboratories valued on earnings and book value?
Ans. Morepen Laboratories Share Price currently reflects a P/E ratio of 41.76 and a P/B ratio of 4.51. EPS is Rs 2.56 and book value is Rs 23.78 per share, giving valuation context.
How do ROE and ROCE look for Morepen Laboratories?
Ans. Morepen Laboratories Share Price is backed by ROE of 11.78% and ROCE of 15.48%. In the same-industry benchmark, ROE is near the median and ROCE sits above both the median and average.
How does Morepen Laboratories compare with healthcare peers?
Ans. Morepen Laboratories Share Price sits near peers such as Orchid Pharma and IOL Chemicals in market cap. Its valuation is above the industry median, while ROCE is better than the benchmark median.
What is the latest revenue and profit data for Morepen Laboratories?
Ans. Morepen Laboratories Share Price can be viewed alongside the latest reported revenue of Rs 5,701.28 crore and net profit of Rs 564 crore for Jun 26. Those figures add financial context to the price event.
What sector and industry does Morepen Laboratories belong to?
Ans. Morepen Laboratories Share Price is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The same-industry benchmark includes 199 companies, which gives the valuation context useful depth. The stock belongs to the Healthcare sector.
Where can I track Morepen Laboratories Share Price on Univest?
Ans. Morepen Laboratories Share Price can be tracked on Univest for live price updates, fundamentals, sector context and 52-week levels. Univest also compiles stock news and company-specific market insights in one place.
